Abbott is recalling 8,174 FreeStyle Libre 3 Sensors, which are components of the FreeStyle Libre 3 Continuous Glucose Monitoring System. These sensors can report inaccurate higher-than-actual glucose levels, which may lead patients to take too much insulin or fail to notice dangerously low blood sugar (hypoglycemia). Consumers should contact their healthcare provider for guidance on managing their glucose monitoring and contact Abbott for further instructions regarding this recall.
The sensors may provide erroneously high glucose results, leading users to administer excessive insulin correctional doses or causing them to miss life-threatening hypoglycemia. This defect can result in severe health consequences including loss of consciousness, seizure activity, coma, permanent neurological damage, or death.
Healthcare provider consultation and manufacturer contact
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท FDA Press Release ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.